| About the author: |
O. I. Kalbus, S. O. Makarov, O. O. Nefodov |
| Heading |
CLINICAL MEDICINE |
| Type of article |
Scentific article |
| Annotation |
The study was devoted to the problem of predicting neurological disorders occurring in patients with systemic lupus erythematosus. Various clinical and paraclinical parameters, such as disease activity, clinical manifestations of the disease, the presence of certain types of antibodies, and so on, have been proposed as possible predictors of the development of neurological disorders in this disease. We performed a comprehensive examination of 64 patients with systemic lupus erythematosus. Based on the obtained results of clinical-neurological, neuropsychological, neuroimaging and immunological studies, we identified the main factors that can be considered predictors of the development of neurological manifestations of systemic lupus erythematosus, the most significant role among which is assigned to antiphospholipid antibodies. Using the obtained data, a predictive model of neurological disorders in patients with lupus was subsequently developed. |
| Tags |
neuropsychiatric systemic lupus erythematosus,autoantibodies,antiphospholipid antibodies,prognosis,predictors |
| Bibliography |
- Makarov SO. Urazhennya nervovoyi systemy pry systemnomu chervonomu vovchaku: aspekty patogenezu, poshyrenict`, poglyady na klasyfikaciyu klinichnykh viyaviv. Ukrayinskiy nevrologichniy zhurnal. 2018; 2: 25–29. [in Ukrainian].
- Ahn GY, Kim D, Won S, Song ST, Jeong HJ, Sohn IW et al. Prevalence, risk factors, and impact on mortality of neuropsychiatric lupus: a prospective, single-center study. Lupus. 2018 Jul;27(8):1338–1347. doi: 10.1177/0961203318772021.
- Alessi H, Dutra LA, Maria L, Xavier P, Couce P, Kayser C, Barsottini O. (Predictive Variables of Cognitive Dysfunction in Patients with Lupus. Neurology.2017 88(16_supplement):1–340.
- Cocco C, Manca E, Corda G, Angioni MM, Noli B, Congia M et al. Brain-reactive autoantibodies in neuropsychiatric systemic lupus erythematosus. Front Immunol. 2023 Jun 13; 14:1157149. doi: 10.3389/fimmu.2023.1157149.
- de Amorim JC, Frittoli RB, Pereira D, Postal M, Dertkigil SSJ, Reis F et al. Epidemiology, characterization, and diagnosis of neuropsychiatric events in systemic lupus erythematosus. Expert Rev Clin Immunol. 2019 Apr;15(4):407–416. doi: 10.1080/1744666X.2019.1564040.6. Ding Y, Zhao J, Qian J, Zhang L, Zhang S, Jiang N et al. The role of anti-ribosomal P autoantibodies in the prediction of neuropsychiatric damage in systemic lupus erythematosus based on CSTAR cohort (XIV). Clin Rheumatol. 2022 May;41(5):1371–1379. doi: 10.1007/s10067-021-06034-6.
- Fujieda Y. Diversity of neuropsychiatric manifestations in systemic lupus erythematosus. Immunol Med. 2020 Dec;43(4):135–141. doi: 10.1080/25785826.2020.1770947.
- Hanly JG, Li Q, Su L, Urowitz MB, Gordon C, Bae SC et al. Psychosis in Systemic Lupus Erythematosus: Results From an International Inception Cohort Study. Arthritis Rheumatol. 2019 Feb;71(2):281–289. doi: 10.1002/art.40764.
- Hanly JG. Attribution in the assessment of nervous system disease in SLE. Rheumatology. 2015 May;54(5):755–756. doi: 10.1093/rheumatology/keu458.
- Hasegawa Y, Arinuma Y, Muramatsu T, Kondou J, Matsueda Y, Kanayama Y et al. The pathogenic role of lupus-specific autoantibodies and Interleukin-6 on demyelination of the brainstem and spinal cord in systemic lupus erythematosus. Lupus. 2023 Mar;32(3):401–410. doi: 10.1177/09612033231151600.
- Ho RC, Thiaghu C, Ong H, Lu Y, Ho CS, Tam WW, Zhang MW. A meta-analysis of serum and cerebrospinal fluid autoantibodies in neuropsychiatric systemic lupus erythematosus. Autoimmun Rev. 2016 Feb;15(2):124–138. doi: 10.1016/j.autrev.2015.10.003.
- Monahan RC, Beaart-van de Voorde LJJ, Steup-Beekman GM, Magro-Checa C, Huizinga TWJ et al. Neuropsychiatric symptoms in systemic lupus erythematosus: impact on quality of life. Lupus. 2017 Oct;26(12):1252–1259. doi: 10.1177/0961203317694262.
- Sarwar S, Mohamed AS, Rogers S, Sarmast ST, Kataria S, Mohamed KH et al. Neuropsychiatric Systemic Lupus Erythematosus: A 2021 Update on Diagnosis, Management, and Current Challenges. Cureus. 2021 Sep 14;13(9): e17969. doi: 10.7759/cureus.17969.
- Tan Z, Zhou Y, Li X, Wang G, Tao J, Wang L et al. Brain magnetic resonance imaging, cerebrospinal fluid, and autoantibody profile in 118 patients with neuropsychiatric lupus. Clin Rheumatol. 2018 Jan;37(1):227–233. doi: 10.1007/s10067-017-3891-3.
- Zardi EM, Giorgi C, Zardi DM. Diagnostic approach to neuropsychiatric lupus erythematosus: what should we do? Postgrad Med. 2018 Aug;130(6):536–547. doi: 10.1080/00325481.2018.1492309.
|
| Publication of the article |
«World of Medicine and Biology» №2(88), 2024 year, 67-71 pages, index UDK 616-002.52:616.8–009–07–037 |
| DOI |
10.26724/2079-8334-2024-2-88-67-71 |
